Identification and cDNA cloning of the transcriptional factors regulating the tissue-specific expression of human alpha-folate receptor gene

调节人α-叶酸受体基因组织特异性表达的转录因子的鉴定及cDNA克隆

基本信息

  • 批准号:
    09670793
  • 负责人:
  • 金额:
    $ 1.86万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

1. I-dentification of the nuclear DNA-binding proteins involving the specific expression of alpha human folate receptor (hFR) gene : we have identified two promoters which are independently active in a tissue-specific manner in regulation of the alpha hFR gene expression. To further characterize the regulation of these promoters, the transcriptional elements involved in the promoter located upstream of exon 1 were investigated in the transport-defective methotrexate-resistant KB cells (02) by sequence analysis of the promoter, gel shift assays, nuclear run-on assays, and RNase protection assays. Compared to wtKB cells grown in physiologic concentrations of folate, we demonstrate that (1) the 02 cells expressed 2% of a hFR protein and its mRNA ; (2) the transcription rate of a hFR gene was reduced 7 fold in the 02 cells relative to wtKB cells ; (3) the nuclear protein(s) that forms a complex with a -352/-461 (109 bp) DNA fragment located approximately 400 bp upstream of the transcription start site was demonstrated in wtKB cells and was significantly reduced in the C2 cells ; (4) based on competitive gel shift assays using several synthetic oligonucleotides corresponding - 426/-461 DNA sequences, a -4391-452 DNA fragment contained the specific binding sites of this nuclear protein(s). This sequence contains potential binding sites of CCAAT-enhancer binding protein beta, GATA-2, and Ets-1. The supershift assays using antibodies against these proteins will be performed to characterize the factor(s) to this region.2. Tissue specific expression of the nuclear factor(s) : the binding of nuclear protein(s) to this DNAfragment was also decreased in MCF-7, MDCK, ACHN, SN12C, and TK- 10 celllines in which expression of the alpha hFR is not detectable. These results suggest that this factor may be involved in the tissue-specific expression of alpha hFR gene and in the modulation of receptor expression in antifolate resistant KB cells.
1.鉴定与α-人叶酸受体(hFR)基因特异性表达有关的核DNA结合蛋白:我们鉴定了两种启动子,它们以组织特异性方式独立地调节α-hFR基因的表达。为了进一步表征这些启动子的调控,通过启动子的序列分析、凝胶迁移试验、核运行试验和RNA酶保护试验,在转运缺陷型甲氨蝶呤耐药KB细胞(02)中研究了位于外显子1上游的启动子中涉及的转录元件。与在生理浓度的叶酸盐中生长的wtKB细胞相比,我们证明:(1)02细胞表达2%的hFR蛋白及其mRNA ;(2)相对于wtKB细胞,02细胞中hFR基因的转录速率降低7倍;(3)与-352/-461(109 bp)形成复合物的核蛋白在转录起始位点上游约400 bp处的DNA片段在wtKB细胞中被证实,并且在C2细胞中显著减少;(4)用几种人工合成的寡核苷酸对-426/-461DNA序列进行竞争性凝胶迁移分析,发现-4391-452DNA片段含有该核蛋白的特异性结合位点。该序列包含CCAAT增强子结合蛋白β、加塔-2和Ets-1的潜在结合位点。将使用针对这些蛋白质的抗体进行超位移测定,以表征该区域的因子。核因子的组织特异性表达:在MCF-7、MDCK、ACHN、SN 12 C和TK- 10细胞系中,核蛋白与该DNA片段的结合也降低,其中未检测到α hFR的表达。这些结果表明,该因子可能参与了α hFR基因的组织特异性表达,并参与了抗叶酸剂耐药KB细胞中受体表达的调节。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nishimura, R.: "Inactivated p16 gene in relapsed childhood acute leukemias as a prognostic determinant." Proc Am Soc Clin Oncol. (in press). (1999)
Nishimura, R.:“失活的 p16 基因在复发性儿童急性白血病中作为预后决定因素。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Wada,H: "Overexpression of multidrug resistance-associated protein (MRP) gene in refractory B-cell non-Hodgkin's lymphoma." International Journal of Pediatric Hematology Oncology. 5・5. 303-312 (1998)
Wada, H:“难治性 B 细胞非霍奇金淋巴瘤中多药耐药相关蛋白 (MRP) 基因的过度表达。”国际儿科血液肿瘤学杂志 5·5 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nishimura, R.: "Microsatellite analysis of childhood leukemia and lymphoma : 9p and 12p abnormalities and expression of related genes." Proc Am Soc Clin Oncol. 17. 545a (1998)
Nishimura, R.:“儿童白血病和淋巴瘤的微卫星分析:9p 和 12p 异常以及相关基因的表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sakakibara,M: "Membrane-type matrix metalloproteinase-1 expression and activation of gelatinase A as prognostic〓 markers in advanced pediatric neuroblastomas." Cancer. 85・1. 231-239 (1999)
Sakakibara, M:“膜型基质金属蛋白酶-1 的表达和明胶酶 A 的激活作为晚期儿童神经母细胞瘤的预后标志物。”85・1 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Saikawa, Y.: "Alteration of the transcriptinal factors involved in the alpha human folate receptor gene expression in transport-defective methotrexate-resistant KB cells." International Journal of Hematology. 67, suppl.107 (1998)
Saikawa, Y.:“在转运缺陷的甲氨蝶呤耐药 KB 细胞中,参与 α 人类叶酸受体基因表达的转录因子的改变。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAIKAWA Yutaka其他文献

SAIKAWA Yutaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAIKAWA Yutaka', 18)}}的其他基金

Computing analysis of leukemic stem cell dynamics in acute myelocytic leukemia
急性粒细胞白血病白血病干细胞动力学的计算分析
  • 批准号:
    19K08356
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Computational leukemic stem cell models in systems biology for predicting relapse and development of risk-stratified chemotherapy
系统生物学中用于预测复发和风险分层化疗发展的计算白血病干细胞模型
  • 批准号:
    20591248
  • 财政年份:
    2008
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Kinetic analysis of minimal residual disease using 3-dimentinal computational models of human granulopoiesis and development of risk of relapse-stratified treatment of pediatric leukemia.
使用人类粒细胞生成的三维计算模型对微小残留病进行动力学分析,并制定儿童白血病复发分层治疗的风险。
  • 批准号:
    17591073
  • 财政年份:
    2005
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Alu-mediated genomic deletion in a case with hemeooxygenase-1 deficiency
血红素加氧酶 1 缺陷病例中 Alu 介导的基因组缺失分析
  • 批准号:
    13670788
  • 财政年份:
    2001
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了